27 January 2022: Clinical Research
Predicting Values of Neutrophil-to-Lymphocyte Ratio (NLR), High-Sensitivity C-Reactive Protein (hs-CRP), and Left Atrial Diameter (LAD) in Patients with Nonvalvular Atrial Fibrillation Recurrence After Radiofrequency Ablation
Bing Ding 1AC* , Pengfei Liu 2BD* , Fangfang Zhang 1F , Jie Hui 1DF , Linyan He 3EF*DOI: 10.12659/MSM.934569
Med Sci Monit 2022; 28:e934569
Table 2 Laboratory and echocardiographic parameters of study population.
| Variable | Nonrecurrent group (n=193) | Recurrent group (n=70) | P value |
|---|---|---|---|
| Glucose(mmol/L) | 5.11 (4.61, 5.61) | 5.06 (4.65, 5.79) | 0.862 |
| Scr(umol/L) | 72.67±17.12 | 73.52±17.60 | 0.724 |
| UA (umol/L) | 348.79±84.50 | 354.29±92.49 | 0.649 |
| TC (mmol/L) | 4.34 (3.86, 5.10) | 4.21 (3.55, 4.67) | 0.027* |
| LDL-C(mmol/L) | 2.48 (2.06, 3.14) | 2.31 (1.87, 2.71) | 0.046* |
| HDL-C(mmol/L) | 1.15 (0.99, 1.36) | 1.10 (0.94, 1.27) | 0.096 |
| TG (mmol/L) | 1.47 (1.06, 2.04) | 1.46 (1.01, 2.16) | 0.673 |
| Lymphocyte count, ×10/L | 1.93 (1.54, 2.38) | 1.85 (1.23, 2.21) | 0.047* |
| Monocyte count, ×10/L | 0.46 (0.38, 0.53) | 0.44 (0.33, 0.58) | 0.619 |
| Neutrophil count, ×10/L | 3.13 (2.50, 3.90) | 3.16 (2.54, 4.05) | 0.373 |
| Platelet count, ×10/L | 188.28±50.19 | 191.09±65.59 | 0.713 |
| NLR | 1.61 (1.27, 2.12) | 1.85 (1.42, 2.49) | 0.011* |
| PLR | 98.52 (76.19, 118.17) | 101.41 (80.76, 135.57) | 0.112 |
| LMR | 4.21 (3.44, 5.32) | 4.10 (2.98, 5.19) | 0.172 |
| hs-CRP, mg/L | 1.06 (0.65, 1.86) | 1.16 (0.76, 3.48) | 0.038* |
| Albumin, g/L | 42.90±3.52 | 42.44±3.66 | 0.354 |
| PT | 11.70 (11.00, 12.70) | 12.40 (11.68, 14.10) | 0.000*** |
| APTT | 29.35 (25.83, 34.28) | 30.25 (26.83, 35.45) | 0.479 |
| INR | 1.02 (0.95, 1.11) | 1.08 (1.02, 1.23) | 0.001** |
| LVEDD, mm | 49 (46, 52) | 51 (47, 53) | 0.023* |
| LVESD, mm | 32 (30, 35) | 34 (31, 36) | 0.027* |
| LAD, mm | 41.58±5.88 | 44.79±5.71 | 0.000*** |
| LVEF, % | 0.63 (0.58, 0.67) | 0.61 (0.57, 0.64) | 0.036* |
| APTT – activated partial thromboplastin time; HDL-C – high-density lipoprotein cholesterol; INR – international prothrombin time standardized ratio; LDL-C – low-density lipoprotein cholesterin; LMR – lymphocyte-to-monocyte ratio; LAD – left atrial diameter; LVEDD – left ventricular end-diastolic dimension; LVESD – left ventricular end-systolic dimension; LVEF – left ventricular ejection fraction; PLR – platelet-to-lymphocyte ratio; PT – prothrombin time; Scr – serum creatinine; TC – total cholesterol; TG – triglyceride; UA – uric acid; * ** *** | |||